Lupus Research Alliance, a member of the Antidote partnership network, is dedicated to finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE) by supporting medical research.
We recently had the pleasure of speaking with Al Roy, Executive Director of Lupus Clinical Investigators Network, an initiative of Lupus Research Alliance. Al shared his thoughts on the importance of medical research for people living with lupus and how patients can be involved every step of the way.
Here are a few key takeaways:
- There has been one new treatment approved for lupus during the last 60 years. To move the needle, people living with lupus must be active partners in their treatment plans and participate in research.
- More than ever, researchers and the FDA are looking for patient input on drug development – from identifying priorities to bringing new treatments to market. To get involved, visit www.lupustrials.org.
- Any time is good for a lupus patient to consider a clinical trial. New scientific breakthroughs allow doctors and researchers to take a more tailored approach to treating individuals’ lupus symptoms. Expect to see more of this precision medicine approach moving forward.
To watch the whole conversation, click on the video below to learn more about how researchers are moving lupus clinical trials forward.
